LENZ Therapeutics LENZ
NASDAQ LENZ
$4.11 +0.01 (+0.24%)
At close: Nov 11, 2026 · 4:00 PM EST

LENZ Therapeutics (LENZ) Asset Utilization Ratio (2025 - 2026)

Updated

LENZ Therapeutics' Asset Utilization Ratio was 0.06 in Q3 2026, down 32.3% from 0.08 a year earlier and down 34.4% from the prior quarter.

Analysis

LENZ Therapeutics (LENZ) Asset Utilization Ratio (2025 - 2026) Analysis & Trends

For FY2025, Asset Utilization Ratio at LENZ Therapeutics came in at 0.07.

  • In earlier years, Asset Utilization Ratio was 0.04 in FY2022.
  • The Q3 2026 figure marks the lowest quarterly Asset Utilization Ratio since Q2 2025.
  • Per Business Quant data, LENZ's Asset Utilization Ratio in the three quarters before Q3 2026 was 0.08 (Q2 2026), 0.07 (Q1 2026) and 0.07 (Q4 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Asset Util. (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn 0.60
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 0.50
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 0.47
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 0.51
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn 0.50
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 0.41
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn 0.62
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn 0.31
10 LENZ Therapeutics 128.82 Mn -839.21 Mn 2.93 Mn 0.06
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 0.06
Jun 30, 2026 0.08
Mar 31, 2026 0.07
Dec 31, 2025 0.07
Sep 30, 2025 0.08
Jun 30, 2025 0.02
API Access

LENZ Therapeutics Asset Utilization Ratio API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=asset-utilization-ratio&ticker=LENZ&period=max&api_key=YOUR_API_KEY